Tentt

Ouro Medicines Acquired by Gilead Sciences — Healthcare M&A

Announced
HealthcareOther

Deal Summary

Gilead Sciences entered a definitive agreement to acquire Ouro Medicines to expand its autoimmune therapy portfolio.

Key Details

Transaction
Gilead Sciences acquires Ouro Medicines
Deal Size
Over $100M
Reported Value
$1.675 billion

Source

Read full article on news.google.com

via GN - entered into definitive agreement · March 24, 2026

Related Deals